Biocon said that its US subsidiary has received supplemental U.S. Food and Drug Administration (FDA) approval for Yesintek (ustekinumab-kfce) single-dose prefilled autoinjector in various strengths.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.